Study of Pulmonary Infections (Pneumonia) in Kidney Transplant Recipients Admitted to Hospital
1 other identifier
observational
132
1 country
1
Brief Summary
The investigators aimed to identify prognosis factors associated with in-hospital complications and assess the epidemiology, management, and outcomes of community-acquired pneumonia in a kidney transplant recipients' cohort. The investigators intend to identify each stay by a national database. Then they will be consulted by 2 clinicians to assert CAP clinical definition. After that radiographic evidence will be reviewed to validate CAP diagnoses. Then clinical data are collected in each center.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2020
CompletedFirst Submitted
Initial submission to the registry
November 17, 2021
CompletedFirst Posted
Study publicly available on registry
December 3, 2021
CompletedSeptember 13, 2022
September 1, 2022
1.2 years
November 17, 2021
September 9, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
In-hospital complications
In-hospital death, transfer to intensive care units (ICU) and prolonged stays
inhospital stay, an average of 30 days
Eligibility Criteria
patients with kidney transplant
You may qualify if:
- kidney transplant recipients
- at least 18 years
You may not qualify if:
- incomplete CAP definition
- hospital-acquired pneumonia
- another diagnosis explaining the symptoms
- patients with non-functional kidney graft
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- CHU de Reimslead
Study Sites (1)
Chu Reims
Reims, 51092, France
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 17, 2021
First Posted
December 3, 2021
Study Start
September 1, 2019
Primary Completion
November 30, 2020
Study Completion
November 30, 2020
Last Updated
September 13, 2022
Record last verified: 2022-09